Evaluating LP-10 in Subjects With OLP

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Oral Lichen Planus
Interventions
DRUG

LP-10 (Liposomal Tacrolimus)

Liposomal oral rinse formulation of Tacrolimus

Trial Locations (7)

14215

Erie County Medical Center, Buffalo

19103

Paddington Testing Co, Inc, Philadelphia

28203

Atrium Health Oral Medicine & Maxillofacial Surgery, Charlotte

33176

Miami Cancer Institue at Baptist Health, Inc, Miami

94143

UCSF School of Dentistry, San Francisco

94538

Center for Dermatology, Fremont

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Lipella Pharmaceuticals, Inc.

INDUSTRY

NCT06233591 - Evaluating LP-10 in Subjects With OLP | Biotech Hunter | Biotech Hunter